CCN2 and cancer: By examining the marker gene expression at transcript and protein levels, CTGF was proven to have the potential to induce transdifferentiation of peritumoral fibroblasts (PTFs) to cancer-associated fibroblasts (CAFs), which had been shown to actively communicate with cancer cells and contribute to tumor progression.